Attenuation of postoperative cognitive dysfunction by amantadine
Attenuation of postoperative cognitive dysfunction by amantadine
批准号:
9125718
负责人:
ZHIYI ZUO
金额:
$23.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2017-04-30
关键词:
AffectAgeAmantadineAmericanAnesthesia proceduresAnestheticsAnimalsAntiviral AgentsAreaAttentionAttenuatedBiochemicalBrainBrain regionCardiac Surgery proceduresCell Culture TechniquesClinicalEffectivenessElderlyFunctional disorderFutureGeneral AnesthesiaGrowthHarvestHippocampus (Brain)HumanImpaired cognitionIntentionInterventionIsofluraneLearningLengthMediatingMemoryMemory impairmentMethodsNeurodegenerative DisordersNeurogliaOperative Surgical ProceduresParkinson DiseasePatientsPharmaceutical PreparationsPopulationProcessProductionQuality of lifeRattusRisk FactorsRoleTestingTranslationsTraumatic Brain InjuryViralagedattenuationbaseconditioned feardesignimprovedimproved outcomein vivomalemortalityneuroinflammationneurotrophic factorolder patientpost-operative cognitive dysfunctionpre-clinicalpublic health relevanceresearch studytherapy designyoung adult
中文摘要
描述(由申请人提供):美国每年有超过2000万人接受手术。术后认知功能障碍(POCD)是一种有文献记载的临床实体,更常发生在老年患者中,已引起公众和专业人士的极大关注。由于这一问题显然很重要,因此迫切需要确定减轻POCD的干预措施。我们的初步研究表明,金刚烷胺是一种临床使用的抗病毒药物,也用于治疗各种神经退行性疾病,减少手术(右颈动脉探查)导致的学习和记忆障碍以及年轻成年大鼠的神经炎症。金刚烷胺还增加了大脑中胶质细胞衍生生长因子(GDNF)的含量。先前的一项研究表明,GDNF可以减少小胶质细胞的激活。此外,我们的初步研究表明,金刚烷胺减轻了手术诱导的老年大鼠的学习和记忆障碍。我们假设GDNF介导金刚烷胺对手术诱导的神经炎症以及老年大鼠学习和记忆障碍的影响。在这个项目中,我们将确定:1)金刚烷胺的应用时间是否影响金刚烷胺减轻手术诱导的老年大鼠学习和记忆障碍的有效性;2)金刚烷胺通过GDNF减少手术引起的神经炎症;以及3)抑制GDNF阻断金刚烷胺导致的颈动脉探查后认知障碍的减轻。我们将使用老年成年雄性大鼠,并对它们进行右侧颈动脉探查。动物将被挥发性麻醉剂异氟醚麻醉。学习和记忆将通过巴恩斯迷宫和恐惧条件反射进行评估。将采集不同的大脑区域进行生化检查。这些研究可能为使用金刚烷胺减轻POCD提供临床前证据。我们的研究还可能揭示金刚烷胺效应的靶分子,这可能有助于设计对POCD的干预措施。
英文摘要
DESCRIPTION (provided by applicant): More than 20 million people each year undergo surgery in the U.S.A. Post-operative cognitive dysfunction (POCD), a documented clinical entity that occurs more frequently in elderly patients, has drawn significant attention from the public and professionals. Because the issue is obviously significant, there is an urgent need to identify interventions to attenuate POCD. Our preliminary study showed that amantadine, a clinically used anti-viral agent that is also used in treating various neurodegenerative diseases, reduced surgery (right carotid exploration)-induced learning and memory impairment as well as neuroinflammation in young adult rats. Amantadine also increased glial cell-derived growth factor (GDNF) in the brain. GDNF has been shown to reduce microglial activation in a previous study. In addition, our preliminary study showed that amantadine attenuated surgery-induced learning and memory impairment in elderly rats. We hypothesize that GDNF mediates the amantadine effects on surgery-induced neuroinflammation as well as learning and memory impairment in aged rats. In this project, we will determine whether: 1) the duration of amantadine application affects the effectiveness of amantadine to attenuate surgery-induced learning and memory impairment in aged rats; 2) amantadine reduces surgery-induced neuroinflammation through GDNF; and 3) inhibition of GDNF blocks amantadine-induced attenuation of cognitive impairment after carotid arterial exploration. We will use old adult male rats and subject them to right carotid arterial exploration. Animals will be anesthetized by the volatile anesthetic isoflurane. Learning and memory will be evaluated by Barnes maze and fear conditioning. Various brain regions will be harvested for biochemical examination. These studies may provide preclinical evidence for using amantadine to attenuate POCD. Our studies may also reveal target molecules for the amantadine effects, which may help design interventions for POCD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
-
批准号:9884819
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2018
-
负责人:ZHIYI ZUO
-
依托单位:
Obesity-induced cerebral vascular remodeling and poor brain ischemic tolerance
-
批准号:10380594
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2018
-
负责人:ZHIYI ZUO
-
依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
-
批准号:9769801
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2017
-
负责人:ZHIYI ZUO
-
依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
-
批准号:10246802
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2017
-
负责人:ZHIYI ZUO
-
依托单位:
Glial cell line-derived neurotropic factor and postoperative cognitive impairment in young rats
-
批准号:10012940
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2017
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic effects on aging brain
-
批准号:8293755
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic effects on aging brain
-
批准号:8727057
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic effects on aging brain
-
批准号:8549264
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2012
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7879848
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2009
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:6826226
-
项目类别:
-
资助金额:$28.21万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:6728964
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:7163021
-
项目类别:
-
资助金额:$26.75万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Neuroprotection after Isoflurane Preconditioning
-
批准号:7004486
-
项目类别:
-
资助金额:$27.55万
-
财政年份:2004
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7173747
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:6696926
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:8067162
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7522567
-
项目类别:
-
资助金额:$28.52万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:6574563
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:7014017
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
Volatile anesthetic modulation of glutamate transporters
-
批准号:6844305
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2003
-
负责人:ZHIYI ZUO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: